Three patients had luminal A (patient ID: 83, 116, 129), 3 had luminal B (ID: 117, 128, 144), 2 had HER2-positive (ID: 57, 76), and one had triple-negative (ID: 147) breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.